Top compounds associated with response to MOB3B


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.075 0.03
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA canertinib CTRPv2 pan-cancer AAC 0.078 0.03
mRNA PD-0325901 CCLE pan-cancer AAC 0.09 0.04
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.15 0.04
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.076 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.073 0.04
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA SB52334 GDSC1000 pan-cancer AAC -0.072 0.04
Download CSV